Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Tziomalos, Konstantinos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Vassiliadis, T., Mpoumponaris A., Vakalopoulou S., Giouleme O., Gkissakis D., Grammatikos N., et al. (2010).  Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival.. Hepatol Res. 40(2), 161-70.
Karagiannis, A., Tziomalos K., Papageorgiou A., Kakafika A. I., Pagourelias E. D., Anagnostis P., et al. (2008).  Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.. Expert Opin Pharmacother. 9(4), 509-15.
Milonas, D., & Tziomalos K. (2018).  Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke.. Cardiovasc Hematol Disord Drug Targets. 18(2), 134-138.
Karagiannis, A., Athyros V. G., Papageorgiou A., Tziomalos K., & Elisaf M. (2006).  Should atenolol still be recommended as first-line therapy for primary hypertension?. Hellenic J Cardiol. 47(5), 298-307.
Alkagiet, S., & Tziomalos K. (2018).  Should all hypertensive patients be screened for primary aldosteronism?. Curr Hypertens Rev.
Athyros, V. G., Tziomalos K., Karagiannis A., Anagnostis P., & Mikhailidis D. P. (2010).  Should adipokines be considered in the choice of the treatment of obesity-related health problems?. Curr Drug Targets. 11(1), 122-35.
Tziomalos, K., Giampatzis V., Baltatzi M., Efthymiou E., Psianou K., Papastergiou N., et al. (2014).  Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.. J Clin Hypertens (Greenwich). 16(4), 309-12.
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Sileli M., Savvatianos S., Kakafika A., et al. (2007).  Serum uric acid as an independent predictor of early death after acute stroke.. Circ J. 71(7), 1120-7.
Karagiannis, A., Tziomalos K., Mikhailidis D. P., Semertzidis P., Kountana E., Kakafika A. I., et al. (2010).  Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients.. Neurol Res. 32(3), 326-31.
Athyros, V. G., Giouleme O., Ganotakis E. S., Elisaf M., Tziomalos K., Vassiliadis T., et al. (2011).  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.. Arch Med Sci. 7(5), 796-805.
Athyros, V. G., Tziomalos K., Gossios T. D., Griva T., Anagnostis P., Kargiotis K., et al. (2010).  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.. Lancet. 376(9756), 1916-22.
R
Tziomalos, K., & Hare J. M. (2009).  Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance.. Front Biosci (Landmark Ed). 14, 237-62.
Tziomalos, K., Kakafika A. I., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2009).  The role of statins for the primary and secondary prevention of coronary heart disease in women.. Curr Pharm Des. 15(10), 1054-62.
Karagiannis, A., Mikhailidis D. P., Athyros V. G., Kakafika A. I., Tziomalos K., Liberopoulos E. N., et al. (2007).  The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opin Ther Targets. 11(2), 191-205.
Tziomalos, K. (2017).  The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia.. Curr Pharm Des. 23(10), 1495-1499.
Panidis, D., Tziomalos K., Papadakis E., Chatzis P., Kandaraki E. A., Tsourdi E. A., et al. (2014).  The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.. Clin Endocrinol (Oxf). 80(3), 432-8.
Ioannidou, E., Tseriotis V-S., & Tziomalos K. (2017).  Role of lipid-lowering agents in the management of diabetic retinopathy.. World J Diabetes. 8(1), 1-6.
Chatzis, P., Tziomalos K., Pratilas G. C., Makris V., Sotiriadis A., & Dinas K. (2018).  The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.. Folia Med (Plovdiv). 60(4), 512-520.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2010).  The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.. Curr Opin Cardiol. 25(4), 394-8.
Bouziana, S., Tziomalos K., Goulas A., & Ηatzitolios A. Ι. (2016).  The role of adipokines in ischemic stroke risk stratification.. Int J Stroke. 11(4), 389-98.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Papadopoulou M., Kostaki S., et al. (2015).  Response to "Brachial Systolic Blood Pressure Fails to Predict Short-Term Outcome in Patients With Acute Ischemic Stroke: What About Central Systolic Pressure?".. Am J Hypertens. 28(9), 1181.
Pagourelias, E. D., Gossios T. D., Tziomalos K., Karagiannis A., Geleris P., & Athyros V. G. (2011).  Residual cardiac risk reduction beyond lipid lowering.. Hellenic J Cardiol. 52(3), 197-203.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.